In a recent investment round, the healthtech company Curebay secured Rs 61.8 crore (USD 7.5 million), with Elevar Equity serving as the lead investor.
According to regulatory records acquired from the Registrar of Companies (RoC), the company’s board approved the issuance of 4,80,590 Series A1 CCPS at an issue price of Rs 1287.12 apiece to reach this fundraising milestone, as reported by bwdisrupt.
Read also – Live With Joy – Unique Emerging Brand in Home Healthcare Services
During this funding round, important figures at Curebay, such as the CEO, CTO, and other members of the leadership team, jointly contributed Rs 1.6 million. Notably, Elevar Equity led the round with an investment of Rs 60 crore.
CureBay aims to close the gap in basic healthcare and revolutionise the patient experience in neglected markets.
Read also – [Funding alert] Country Delight Secures $20 Mn Investment From Temasek, Venturi Partners
Previously, in the final quarter of 2022, this Chennai-based firm raised Rs 50 crore in its Series A round, which was headed by Elevar Capital.
About CureBay
CureBay was founded in 2021 to improve access to healthcare in rural areas by using technology to facilitate the last-mile delivery of basic medical care.
Read also – Namma Yatri Join Forces with Bengaluru Police for Women’s Auto Driving
